FDA Warns of Serious Injuries From ‘Off-Label’ Use of the Double-Chin Fat Dissolver

The FDA is warning about serious adverse reactions tied to the unapproved use of Kybella (deoxycholic acid) — the injectable that dissolves fat — reinforcing that the drug is cleared for one specific area only: beneath the chin.

What Kybella actually is

Kybella is an injectable form of deoxycholic acid, a molecule the body naturally uses to break down dietary fat. Injected into fatty tissue, it destroys fat cells. The FDA approved it specifically to reduce submental fat — the “double chin” — in adults, and its safety and dosing were established for that region alone.

The problem: off-label body contouring

As demand for non-surgical fat reduction has surged, providers and consumers have increasingly used deoxycholic-acid injections off-label — on the abdomen, flanks, arms, thighs and other areas the drug was never approved or studied for. The FDA’s action highlights that these unapproved uses have been associated with serious harm, and it has updated the drug’s labeling to warn about adverse reactions linked to such use.

What can go wrong

Because deoxycholic acid destroys tissue indiscriminately, injecting it incorrectly or in the wrong place can cause significant damage. Known adverse reactions include nerve injury (notably to the nerve that controls the smile, causing an uneven expression), tissue death (necrosis), skin ulceration, infection, scarring and hair loss at the injection site, along with pain, swelling and bruising. In sensitive areas, the consequences can be lasting. The drug’s safety margins were characterized only for the under-chin area — so using it elsewhere means operating without that safety data.

Why it matters

The booming market for quick cosmetic fixes has outpaced the evidence, and “fat-dissolving” injections have spread through medspas and social media well beyond their approved use. The FDA’s warning is a reminder that “approved for one thing” is not “safe for everything”: a drug’s approval is tied to a specific indication, dose and body region, and stepping outside that can carry real, sometimes permanent, risk. Consumers considering fat-dissolving injections should ask exactly what is being injected, whether it is FDA-approved for that body area, and who is administering it. This is regulatory/safety news, not medical advice.